SCHD and SPYM overlap by 7.6%: that much of every dollar in either fund is invested exactly as the other fund invests it. They have 46 companies in common, the heaviest first below.
Also searched as SPYM vs SCHD.
The two filings describe different dates, 31 May 2026 for SCHD and 30 June 2026 for SPYM, so part of any difference is a month of drift rather than a difference in what the funds hold.
The heaviest companies both funds hold. The shared figure is the smaller of the two weights, which is the part of each dollar that lands in the same place either way.
#
Company
SCHD
SPYM
1
UnitedHealth Group Inc
5.09%
0.58%
2
Home Depot Inc/The
3.36%
0.54%
3
Procter & Gamble Co/The
3.55%
0.53%
4
Merck & Co Inc
3.86%
0.49%
5
Coca-Cola Co/The
3.96%
0.49%
6
Chevron Corp
3.83%
0.48%
7
Texas Instruments Inc
5.90%
0.42%
8
Amgen Inc
3.47%
0.30%
9
QUALCOMM Inc
6.74%
0.30%
10
PepsiCo Inc
3.44%
0.29%
11
Verizon Communications Inc
3.65%
0.27%
12
Abbott Laboratories
2.96%
0.24%
13
ConocoPhillips
3.51%
0.20%
14
Altria Group Inc
2.94%
0.19%
15
Bristol-Myers Squibb Co
2.93%
0.18%
16
Lockheed Martin Corp
2.70%
0.16%
17
Automatic Data Processing Inc
2.25%
0.14%
18
Comcast Corp
2.25%
0.14%
19
Blackstone Inc
2.20%
0.14%
20
United Parcel Service Inc
1.98%
0.12%
21
Accenture PLC
2.90%
0.12%
22
SLB Ltd
2.05%
0.11%
23
EOG Resources Inc
1.82%
0.11%
24
Target Corp
1.45%
0.09%
25
Fastenal Co
1.28%
0.09%
Where they differ
SCHD reports 99 holdings and SPYM reports 506. 46 of them appear in both, which leaves 53 only in SCHD and 460 only in SPYM.
Both sets of holdings come from the funds' own Form N-PORT filings with the SEC, covering 99.77% of SCHD and 99.87% of SPYM. Overlap is the sum of the smaller weight over every company both funds hold. Costs are as stated in each fund's prospectus, and yields come from our market data provider.
Now see it across a whole portfolio
Holding SCHD and SPYM together is common. Vestiio opens every fund in a portfolio and shows which companies turn up in more than one of them, and how much of your money that is. Start a free 14-day Premium trial and import your own holdings to see it across your whole portfolio. No credit card.
Fund Explorer is informational research only. Not investment advice. Vestiio is not supervised by FINMA.
SEC 13F filings are delayed manager-level disclosures and do not show the full portfolio, including cash,
shorts, private assets, many derivatives, fees, leverage, or trades made between reporting dates.